系统性审查:炎症性肠病过渡期护理中的实践和计划
Patrick Chan1,2, Jack McNamara1,3, Angharad Vernon-Roberts4
1Department of Gastroenterology and Hepatology, Liverpool Hospital, Liverpool, New South Wales, Australia.
Inflammatory bowel diseases
|August 28, 2024
概括
结构化的过渡计划改善了患有炎症性肠病 (IBD) 的青少年的结果. 然而,目前的做法缺乏标准化,需要进一步研究最佳的护理模式.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 青少年医学 青少年医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 对于患有炎症性肠病 (IBD) 的青少年,将其转移到成人护理中,带来了重大挑战.
- 结构化过渡计划越来越多地被采用,但最佳格式需要澄清.
研究的目的:
- 系统地审查IBD青少年的结构化过渡计划.
- 评估这些计划及其组成部分对疾病特异性和转型相关结果的影响.
主要方法:
- 在四个主要数据库 (PubMed,CINAHL,CENTRAL,EMBASE) 进行了系统审查,截至2023年3月.
- 根据PRISMA指南,包括评估结构化过渡计划或测量过渡/疾病结果的干预措施的研究.
主要成果:
- 包括29项研究,其中21项报告结构化计划和8项离散干预.
- 计划改善了知识,自我效能,坚持和准备;干预措施降低了复发/入院率和皮质类固醇使用.
- 证据质量受到异质性和方法论问题的限制.
结论:
- 结构化计划有利于青少年IBD患者的过渡和医疗结果.
- 当前的实践存在显著的差异,突出了对标准化过渡模型的需求.
- 进一步的研究对于制定基于证据的指导方针和护理模式至关重要.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
122
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
122
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
328
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
328
Inflammatory Bowel Disease V: Surgical Management
133
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
133
Inflammatory Bowel Disease II: Crohn's Disease
205
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
Inflammatory Bowel Disease I: Ulcerative Colitis
159
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
159
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145


